BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 136072)

  • 1. Inability of normal and activated thymus-derived cells to act as cytotoxic effector cells against antibody-coated targets.
    Forman J; Britton S; Möller G
    Transplantation; 1976 Oct; 22(4):374-9. PubMed ID: 136072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells.
    Forman J; Möller G
    J Exp Med; 1973 Sep; 138(3):672-85. PubMed ID: 4269560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.
    Waterfield JD; Waterfield EM; Möller G
    Cell Immunol; 1975 Jun; 17(2):392-404. PubMed ID: 805001
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte-mediated cytotoxicity against tumor cells. III Differentiation of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):317-20. PubMed ID: 136357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fc receptor on thymus-derived lymphocytes: II. Mitogen responsiveness of T lymphocytes bearing the Fc receptor.
    Stout RD; Herzenberg LA
    J Exp Med; 1975 Nov; 142(5):1041-51. PubMed ID: 1081574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of the Fc receptor on mixed lymphocyte culture-activated T blasts.
    Hayry P; Andersson LC
    Cell Immunol; 1976 Aug; 25(2):237-44. PubMed ID: 133765
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S; Smith KA
    J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells.
    Forman J; Britton S
    J Exp Med; 1973 Feb; 137(2):369-86. PubMed ID: 4539847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 12. Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes.
    Krammer PH; Hudson L; Sprent J
    J Exp Med; 1975 Dec; 142(6):1403-15. PubMed ID: 1081578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-mediated cytotoxicity against tumor cells II. Characteristics and tissue distribution of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):309-16. PubMed ID: 1086781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some characteristics of the antibody-induced cell-mediated cytotoxicity against leukemia cells.
    Britton S; Forman J
    Transplantation; 1974 Feb; 17(2):180-7. PubMed ID: 4590289
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements.
    Stukart MJ; Vos A; Melitef CJ
    Eur J Immunol; 1981 Mar; 11(3):251-7. PubMed ID: 6972310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in the mitogen responsiveness of lymphocytes from mice bearing Moloney sarcoma virus induced tumors.
    Marshall GD; Thurman GB; Foster BG; Goldstein A
    Immunol Commun; 1977; 6(6):603-15. PubMed ID: 304835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice.
    Ahituv A; Naor D; Sharon R; Tarcic N; Klein BY
    Cancer Immunol Immunother; 1982; 14(1):16-26. PubMed ID: 6186365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pokeweed mitogen-, concanavalin A-, and phytohemagglutinin-induced development of cytotoxic effector lymphocytes. An evaluation of the mechanisms of T cell-mediated cytotoxicity.
    Kirchner H; Blaese RM
    J Exp Med; 1973 Oct; 138(4):812-24. PubMed ID: 4542736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity.
    Galili U; Schlesinger M
    J Immunol; 1975 Sep; 115(3):827-33. PubMed ID: 125304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.